The company’s most recent operating revenue was generated from medical cannabis product sales and related services (contract manufacturing, laboratory services, and marketing/distribution commissions). Following the transfer of assets and liabilities under an economic rehabilitation plan, it ceased operations and is being maintained for sale as a public listed shell.
